GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Inventories, Raw Materials & Components

ANL (Adlai Nortye) Inventories, Raw Materials & Components : $0.00 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Inventories, Raw Materials & Components?

Adlai Nortye's inventories, raw materials & components for the quarter that ended in Jun. 2024 was $0.00 Mil.


Adlai Nortye Inventories, Raw Materials & Components Historical Data

The historical data trend for Adlai Nortye's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Inventories, Raw Materials & Components Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
- - -

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Inventories, Raw Materials & Components Get a 7-Day Free Trial - - - - -

Adlai Nortye Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Adlai Nortye Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Inventories, Raw Materials & Components
Traded in Other Exchanges
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.